China’s edge in fast, cost-effective early clinical trials has propelled its emergence as a global biopharmaceutical powerhouse, but there is a risk that the United States could take steps to curb ...

Veradigm says an unauthorized threat actor with stolen credentials was able to access and copy the personal data of patients, according to a report this week filed with the U.S. Securities and ...

As the Department of Medical Education highlights the teams that educate our students and carry out the mission of Heersink School of Medicine, we want to turn to the individuals who manage the ...

Lucas Kloberdanz-Dyck is a writer for Collider. He grew up creating lists, stories, and worlds, which led to his love of anime and video games. He attended Sheridan College where he earned an Honours ...

Modular Regulatory Strategy Creates Defined Milestone Cadence, Enables Earlier FDA Engagement, and Supports Targeted Final Clinical Module Submission Planned for Q2 2027 White Bear Lake, ...

This new platform bridges the gap between routine patient care and clinical research, creating a single, comprehensive wound data backbone for sponsors and research sites. BOCA RATON, Fla., April 23, ...

Medical practices often find themselves dealing with IT disruptions and data breach cleanup involving third-party vendors. (Image: Getty Images) Vendor security risk has long been a source of pain for ...

VADUZ, Liechtenstein, June 24, 2025 /PRNewswire/ --Implantica AG (publ.), a MedTech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop® ...

Health care tech company Veradigm said yesterday it could not find a buyer during a review of strategic alternatives and it is now conducting another review to find ways to improve its organization ...

Ayush Pande is a PC hardware and gaming writer. When he's not working on a new article, you can find him with his head stuck inside a PC or tinkering with a server operating system. Besides computing, ...

Robbie has been an avid gamer for well over 20 years. During that time, he's watched countless franchises rise and fall. He's a big RPG fan but dabbles in a little bit of everything. Writing about ...